Clinic
Chippenham & Johnston-Willis Hospitals, INC.
Chippenham & Johnston-Willis Hospitals, INC. was paid $2.80M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99283, emergency room visit (moderate) — 54% of everything it billed.
33Billing provider infoCHIPPENHAM & JOHNSTON-WILLIS HOSPITALS, INC.
CHESTERFIELD, VA 23832
CHESTERFIELD, VA 23832
33aNPI1205200599assigned 11/24/2015
33bProvider typeEmergency Care Clinic/Center
28Total paid$2.80M
24GClaims47,556
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Virginia
Rank by total paid#2 of 10
Median peer was paid$264K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,327 | $163K | |
| 2019 | 3,449 | $228K | |
| 2020 | 4,352 | $299K | |
| 2021 | 7,173 | $413K | |
| 2022 | 10,374 | $589K | |
| 2023 | 10,569 | $636K | |
| 2024incomplete | 9,312 | $472K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 54% | 8,709 | 7,791 | $1.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 3,625 | 3,315 | $638K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 16% | 2,613 | 2,348 | $454K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 288 | 276 | $66K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 115 | 104 | $37K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 124 | 119 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 116 | 107 | $22K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,166 | 956 | $18K |
| 80053 | Comprehensive metabolic panel | <1% | 2,295 | 2,109 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,350 | 1,194 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 820 | 784 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,087 | 1,030 | $2K |
28 more codes
| 85027 | <1% | 3,403 | $2K | |
| 84484 | <1% | 684 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,799 | $762.98 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,075 | $723.91 |
| 83690 | <1% | 1,100 | $689.13 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,989 | $529.83 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,140 | $237.19 |
| 81001 | <1% | 1,797 | $211.79 | |
| 71045 | Radiologic examination, chest; single view | <1% | 280 | $178.07 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 194 | $147.39 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 763 | $122.51 |
| 81025 | <1% | 1,178 | $110.51 | |
| 87070 | <1% | 915 | $85.98 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,249 | $79.29 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,800 | $65.44 |
| 80076 | <1% | 52 | $60.61 | |
| 83735 | <1% | 661 | $51.22 | |
| 81003 | <1% | 547 | $39.19 | |
| 87807 | 0% | 262 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 659 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 31 | $0.00 |
| 84703 | 0% | 57 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 19 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 43 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 510 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 12 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOSNESS, DUSTIN (CFO)
Parent organizationCHIPPENHAM & JOHNSTON-WILLIS HOSPITALS, INC.
| Provider | Location | Paid |
|---|---|---|
| Chippenham & Johnston-Willis Hospitals INC | Richmond, VA | $103.74M |
| Chippenham & Johnston-Willis Hospitals, INC. | Richmond, VA | $285K |
| Chippenham & Johnston-Willis Hospitals INC | Richmond, VA | $216.11 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.